Head of Urology @Krankenhaus Nordwest / Frankfurt Main Professor of Urology and Researcher
Joined February 2017
- Tweets 192
- Following 123
- Followers 122
- Likes 41
1 Photos and videos
Inga Peters retweeted
Jun 2
Kidney SABR on the front cover of @TheLancetOncol. A well-deserved recognition for @_ShankarSiva for his work and efforts over the past 10 years.
thelancet.com/journals/lanon…
2
37
97
28,101
Inga Peters retweeted
1 Nov 2023
JUST IN (and finally...): Pembrolizumab hits OVERALL SURVIVAL in KYN-564 adjuvant study in Kidney Cancer!!!
The time has finally come... via @BusinessWire
@DanaFarber_GU @tompowles1 @OncoAlert @OncBrothers @OncLive @TargetedOnc @urotoday @Uromigos @ALLIANCE_org @eaonc @SWOG
businesswire.com/news/home/2…
14
169
486
86,473
Inga Peters retweeted
12 Jun 2023
@BenjaminPradere and Arlene Siefker-Radtke on phase 2 #NORSE and phase 3 #THOR study results with #erdafitinib in metastatic #UrothelialCancer
👉@Uroweb podcast: uroweb.org/education-events/…
12 Jun 2023
Dr. Siefker-Radtke reveals promising details from 2 #mUC studies in a 🆕 #EAUpodcast with @BenjaminPradere at #ASCO23.
➡️Norse: erdafitinib (45% RR) vs erdafitinib cetrelimab (55% RR)
➡️THOR: erda OS benefits compared to chemotherapy
🎧Learn more 👇 ow.ly/8hv150OLx0q
5
9
1,934
Inga Peters retweeted
14 Feb 2023
Yet another trial of focal thermoablation, cryo, proving substandard results - 35% still had csPCa (only 46% had no PCa, and that neither MRI nor PSA were good indicators. Why is there no biochemical analysis to explain it? @BehfarEdhaie onlinelibrary.wiley.com/doi/…
4
9
21
16,575
Inga Peters retweeted
13 Feb 2023
@ASCO #GU23 Abs#18👉 bit.ly/3E65gfs by @AlanBryce9 et al 👉Rucaparib significantly improved rPFS vs either docetaxel or abi/enza in BRCA/ATM mCRPC #prostatecancer. OS trending favorably in BRCA pts @kalasri3 @oncoalert @urotoday @PCF_Science @uromigos
2
33
56
12,905
Inga Peters retweeted
29 Jan 2023
#Operieren in der #Schwangerschaft ist möglich! Dennoch wird es schwangeren Chirurginnen auch heutzutage immer noch in vielen Kliniken schwer gemacht. Das führt zu Verzögerungen in der operativen Ausbildung und stellt für viele Frauen einen unnötigen Karrierenachteil dar.
1
4
6
745
Inga Peters retweeted
29 Dec 2022
5/ IL-15 superagonist NAI can induce persistent CR in 71% of BCG-unresponsive #NMIBC with #CIS 89% avoided cystectomy and 100% DSS at 2 years.
@UroCancerMD @UclaUrology @drpatrick @NEJMEvidence
evidence.nejm.org/doi/full/1…
2
8
35
6,838
Inga Peters retweeted
29 Dec 2022
1/ #ARASENS phase 3 trial shows ⬆️OS with darolutamide in combination with docetaxel and ADT in #mHSPC (vs docetaxel ADT alone) with similar AE profile, leading to @US_FDA approval.
#MatthewSmith @BertrandTOMBAL @MGHMedicine @NEJM
nejm.org/doi/full/10.1056/NE…
2
22
66
13,738
Inga Peters retweeted
28 Dec 2022
#Frailty assessment has clinical utility in cancer treatment. Analyses of #pazopanib vs. chemo in sarcoma pts.:
👉#geriatric & functional assessment - more important than age
👉both associate with oncological outcomes and tolerability
sciencedirect.com/science/ar…
6
19
2,906
Inga Peters retweeted
4 Oct 2022
Breaking news: Phase 3 randomized TALAPRO-2 trial of Enza Talazoparib vs. Enza meets primary endpoint in the 1st line mCRPC #ProstateCancer in both HRR and HRR- patients (study design👇).Press release 👉 bit.ly/3SSjJAp @OncoAlert @urotoday @Huntsman_GU @PCF_Science
15
133
274
Inga Peters retweeted
23 Sep 2022
Just In @KCA_Journal :👉Excellent commentary on the evaluation of the optimal duration of Immunotherapy in #kidneycancer by Dr. Mamta Parikh & @PrimoLaraMD @UCD_Cancer 👉Need for prospective clinical trials👉bit.ly/3S16wFL @Oncoalert @KidneyCancer @SWOG
1
26
49
Inga Peters retweeted
21 Sep 2022
Data from the Foxpro Trial on ultra focal therapy presented by @HardenbergJost @dgukongress focal therapy session. Critical discussion. Ultra focal Not the way to go @martin_schostak @IngaPeters2017 @JPRadtke
4
9
Inga Peters retweeted
15 Sep 2022
Just in @CCR_AACR: Happy to report👉SPOP mutation as 1st treatment selection biomarker in mCSPC #ProstateCancer , predicts response to ARAT & not to docetaxel bit.ly/3U1d88k @neerajaiims @EAntonarakis @RyonGraff @geoff_oxnard @OncoAlert @PCF_Science Tweetorial (1/10)
14
101
289
Inga Peters retweeted
18 Jul 2022
ctDNA (Natera) extending is role into adjuvant bladder cancer with Medicare coverage. ctDNA identifies a high risk group . The R3 (011) trial will validate the role of atezolizumab in this setting. Recruitment and sites needed prnewswire.com/news-releases… @NateraGenetics
33
78
Inga Peters retweeted
19 Jul 2022
Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men pubs.rsna.org/doi/10.1148/ra… #ProstateCancer #medtwitter #CancerResearch
1
12
41
Inga Peters retweeted
3 Jun 2022
Tamsulosin facilitates passage of renal stones after ESWL .
#ESWL #Urolithiasis #urology
A randomized trial of adjuvant tamsulosin as a medical expulsive therapy for renal stones after shock wave lithotri… pubmed.ncbi.nlm.nih.gov/3557…
1
1
4
Inga Peters retweeted
4 May 2022
Whilst PROMS score summaries are important, and shown in the PROTECT NEJM QoL paper, these data present the very significant side effects from radical therapy in a manner that is more easily understood by patients (and me).
4 May 2022
The ProtecT team releases another analysis that shows what happened to 2,565 men with prostate cancer who were randomly assigned to receive surgery, radiation therapy, or active monitoring. #pcsm #radonc @QuinteTBristol
6
15
Inga Peters retweeted
13 Apr 2022
PD-L1 is a very unreliable biomarker in RCC as it is in bladder cancer. We can and must do better to find predictive tools.
13 Apr 2022
The limited role of PD-L1 as predictive biomarkers in mRCC
@fsgimt
15
54
Inga Peters retweeted
19 Feb 2022
Sarcomatoid histology a good biomarker associated with greater benefit to adjuvant Pembro in RCC.
26
105
Inga Peters retweeted
23 Jan 2022
Malignancy risk stratification of cystic renal lesions based on a contrast-enhanced CT-based machine learning model and a clinical decision algorithm link.springer.com/article/10… #radiomics #CancerResearch #MedTwitter
4
12